Role of cell cycle in mediating sensitivity to radiotherapy

International Journal of Radiation Oncology, Biology, Physics
Timothy M Pawlik, Khandan Keyomarsi

Abstract

Multiple pathways are involved in maintaining the genetic integrity of a cell after its exposure to ionizing radiation. Although repair mechanisms such as homologous recombination and nonhomologous end-joining are important mammalian responses to double-strand DNA damage, cell cycle regulation is perhaps the most important determinant of ionizing radiation sensitivity. A common cellular response to DNA-damaging agents is the activation of cell cycle checkpoints. The DNA damage induced by ionizing radiation initiates signals that can ultimately activate either temporary checkpoints that permit time for genetic repair or irreversible growth arrest that results in cell death (necrosis or apoptosis). Such checkpoint activation constitutes an integrated response that involves sensor (RAD, BRCA, NBS1), transducer (ATM, CHK), and effector (p53, p21, CDK) genes. One of the key proteins in the checkpoint pathways is the tumor suppressor gene p53, which coordinates DNA repair with cell cycle progression and apoptosis. Specifically, in addition to other mediators of the checkpoint response (CHK kinases, p21), p53 mediates the two major DNA damage-dependent cellular checkpoints, one at the G(1)-S transition and the other at the G(2)-M tran...Continue Reading

References

Nov 1, 1977·Clinical Otolaryngology and Allied Sciences·L A Price, B T Hill
Feb 1, 1976·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L M Van PuttenJ H Mulder
Mar 1, 1977·Experimental Cell Research·M L MeistrichB Barlogie
Nov 1, 1977·Journal of the American Geriatrics Society·K Steel
Nov 3, 1989·Science·L H Hartwell, T A Weinert
Sep 1, 1984·Molecular and Cellular Biology·W Maltzman, L Czyzyk
Nov 1, 1994·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·R N KolesnickZ Fuks
Sep 7, 1995·The New England Journal of Medicine·M Kastan
Sep 1, 1995·Genes & Development·P SabbatiniE White
Mar 3, 1995·Science·S M CrossB J Reid
Aug 1, 1994·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·L Minarik, E J Hall
Dec 16, 1994·Science·L H Hartwell, M B Kastan
Feb 1, 1993·Gynecologic Oncology·A SterenH E Averette
Sep 1, 1993·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·K SkladowskiG G Steel
Sep 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·W SiedeE C Friedberg
Mar 1, 1993·Molecular and Cellular Biology·E Yonish-RouachM Oren
Jun 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·J M Lee, A Bernstein
Jul 1, 1996·Nature Genetics·C A WilsonD I Slamon
Sep 1, 1996·Molecular and Cellular Biology·J ChenA Dutta
Mar 1, 1996·Cancer Metastasis Reviews·R E MeynL Milas
Jan 1, 1997·Molecular and Cellular Biology·C G Maki, P M Howley
Dec 24, 1996·Proceedings of the National Academy of Sciences of the United States of America·N S PellegataE J Stanbridge
Feb 7, 1997·Cell·S Nagata
Apr 1, 1997·Current Opinion in Genetics & Development·M F Hoekstra
Mar 1, 1997·International Journal of Radiation Oncology, Biology, Physics·N GuptaD F Deen
Jan 1, 1997·Annual Review of Immunology·M F Lavin, Y Shiloh
May 15, 1997·Nature·Y HauptM Oren
May 15, 1997·Nature·M H KubbutatK H Vousden

❮ Previous
Next ❯

Citations

Jun 8, 2010·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Kuan-Hsuan ChenYi-Wei Chen
Feb 23, 2011·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Volker Hans SchartingerJózsef Dudás
Feb 12, 2008·Annals of Biomedical Engineering·Ana NiciforovicMarija B Radojcic
Jul 27, 2010·Acta Biotheoretica·Heiko EnderlingPhilip Hahnfeldt
Mar 29, 2012·Cell Biology and Toxicology·Fatema A DhariwalaMalini Krishna
Jul 13, 2013·Cellular and Molecular Neurobiology·Yuanyuan XuFenju Liu
Apr 21, 2011·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Ming TianJianping Gong
Apr 28, 2010·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Caryne Margotto BertolloAlfredo Miranda Goes
May 5, 2010·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Li WangDaiming Fan
May 23, 2006·Biochemical and Biophysical Research Communications·Yulei DuDaiming Fan
Dec 4, 2012·Cancer Letters·Delphine Tamara Marie-EgyptienneRichard Peter Hill
Oct 4, 2005·International Journal of Radiation Oncology, Biology, Physics·Nathalie CrokartBernard Gallez
Oct 13, 2011·Nature Communications·Jeffrey AtkinsonValerian E Kagan
Jul 3, 2008·Cancer Biotherapy & Radiopharmaceuticals·Tongbo YiZhengyan Wu
Dec 23, 2009·Cancer Biotherapy & Radiopharmaceuticals·Xufeng ChenJeffrey Y C Wong
Aug 25, 2012·Cancer Biotherapy & Radiopharmaceuticals·Li WangJuLun Yang
Dec 28, 2012·Cancer Biotherapy & Radiopharmaceuticals·Young-Mee Kim, Hongryull Pyo
Oct 16, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Lina KrasnyYosef S Haviv
Nov 8, 2011·Photochemistry and Photobiology·Anja HeselichPaul G Layer
Jul 24, 2010·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Ling-Fei WuBi-Liu Wei
Apr 9, 2009·Cancer Research·Stephanie Harkey ShirleyRobin Fuchs-Young
Feb 2, 2013·Therapeutic Advances in Urology·Kent Yip, Roberto Alonzi
May 25, 2010·Cancer Cell International·Zhen Y YouJun J Wang
Sep 27, 2013·Journal of Translational Medicine·Chen-Hsi HsiehYu-Jen Chen
Feb 14, 2006·Theoretical Biology & Medical Modelling·Benjamin RibbaSantiago Schnell

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Ataxia telangiectasia

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis